Western Reserve University, a Visiting Fellow at the NIH, a Scientist at the FDA's NCTR, and a Senior Scientist at American Home Products and BASF.

integrating approaches from multidisciplinary fields of bioinformatics, chemoinformatics, computational toxicology, and information technologies with the objectives of knowledge discovery and the elucidation of mechanism of toxicity in June 2002. Dr Tong received his BSc in Chemistry and PhD in Polymer Chemistry from Fudan University, and was a research associate in Computational Chemistry for six years at the University of Missouri-St Louis. In 1996, he joined an on-site IT contractor at the FDA's NCTR to develop chemoinformatics approaches for managing and predicting hormone-related and endocrine-disrupting compounds. He then became Manager of the Computational Science and Bioinformatics group for genomic, proteomic and metabonomic research as well as traditional toxicological studies at NCTR. Dr Xian-Ping Lu was Director of Research at Galderma R&D in Princeton before leading a group of scientists trained in the US to found Chipscreen Biosciences Ltd, a chemogenomics-based drug discovery company, and becoming Chief Scientific Officer. Dr Lu is experienced in drug discovery and development with more than 20 inventions and patent applications in several small molecule therapeutic areas. Dr Lu gained a BSc i